Literature DB >> 5414562

Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.

D R Mishell, M E Lumkin.   

Abstract

Keywords:  Anabolic Steroids; Androgens; Biology; Bleeding; Clinical Research; Contraception--side effects; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Diseases; Endocrine System; Evaluation; Family Planning; Hormones; Medroxyprogesterone Acetate; Metrorrhagia; Physiology; Research Methodology; Research Report; Signs And Symptoms; Vaginal Rings

Mesh：

Substances：

Year:  1970        PMID： 5414562     DOI： 10.1016/s0015-0282(16)37333-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  7 in total

1.  Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

Review 2.  Hormonal steroid contraceptives. II. Clinical considerations.

Authors:  G C Liggins
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.

Authors:  Craig J Hoesley; Beatrice A Chen; Peter L Anderson; Charlene S Dezzutti; Julie Strizki; Carol Sprinkle; Faye Heard; Jose Bauermeister; Wayne Hall; Cindy Jacobson; Jennifer Berthiaume; Ashley Mayo; Holly Gundacker; Nicola Richardson-Harman; Jeanna Piper
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

Review 4.  Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Jennifer A Hurlburt; Gustavo F Doncel
Journal:  Int J Womens Health       Date:  2013-10-21

5.  Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.

Authors:  John W McBride; Peter Boyd; Nicola Dias; David Cameron; Robin E Offord; Oliver Hartley; Vicky L Kett; R Karl Malcolm
Journal:  J Control Release       Date:  2019-02-04       Impact factor: 9.776

6.  Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.

Authors:  David F Archer; Ruth B Merkatz; Luis Bahamondes; Carolyn L Westhoff; Philip Darney; Dan Apter; Jeffrey T Jensen; Vivian Brache; Anita L Nelson; Erika Banks; György Bártfai; David J Portman; Marlena Plagianos; Clint Dart; Narender Kumar; George W Creasy; Regine Sitruk-Ware; Diana L Blithe
Journal:  Lancet Glob Health       Date:  2019-06-20       Impact factor: 26.763

Review 7.  Recent progress in advanced biomaterials for long-acting reversible contraception.

Authors:  Mingzhe Yan; Yanming Zhang; Zhihang Wu; Yifei Li; Keke Dou; Banghui Wang; Yingruo Wang; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2022-03-17       Impact factor: 10.435
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.